Advanced Technologies for Novel Therapeutics

Basic Information

211 Warren St
Box 69
Newark, NJ, 07103-3568

Company Profile

n/a

Additional Details

Field Value
DUNS: 828579008
Hubzone Owned: Y
Socially and Economically Disadvantaged: Y
Woman Owned: Y
Number of Employees: 7


  1. SBIR Phase I: Preparation and Characterization of Polymer based Biodegradable Nanoparticles of Novel Inhibitors of Cell Proliferation

    Amount: $150,000.00

    This Small Business Innovation Research (SBIR) Phase I project will study the preparation and characterization of polymer based biodegradable nanoparticles of novel inhibitors of cell proliferation. T ...

    SBIR Phase I 2013 National Science Foundation

Agency Micro-sites

US Flag An Official Website of the United States Government